| Updated in 4/14/2018 1:02:37 AM |
Viewed: 194 times |
(Journal Article) |
Synthesis of the Alzheimer Drug Posiphen into Its Primary Metabolic Products N1norPosiphen N8norPosiphen and N1 N8bisnorof Amyloid Precursor Protein Synuclein Synthesis Interleukin1 Release and Cholinergic Action AntiInflammatory AntiAllergy Agents in Medicinal 12 2 (2013): 117-28
Lahiri, Rogers, and Greig.
K Yu
,
Qian-Sheng Marcella
,
A Mohammad
,
Kamal Kumar
,
T Jack
,
W Harold
,
H Nigel
,
Holloway Weiming
,
Sambamurti Balmiki
,
Posiphen Their
,
AIAAMC Chemistry
Notes
[Original String]:
192. Yu, Qian-Sheng, Marcella Reale, Mohammad A. Kamal, Harold W. Holloway, Weiming Luo, Kumar Sambamurti, Balmiki Ray, Debomoy K. Lahiri, Jack T. Rogers, and Nigel H. Greig. "Synthesis of the Alzheimer Drug Posiphen into Its Primary Metabolic Products ( )-N1-norPosiphen, ( )-N8-norPosiphen and ( )-N1, N8-bisnorPosiphen, Their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action." Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry AIAAMC 12.2 (2013): 117-28.